Cargando…
Immune checkpoint inhibitor-induced takotsubo syndrome and diabetic ketoacidosis: rare reactions
Immune checkpoint inhibitors (ICIs) are increasingly used to treat certain malignancies due to their higher efficacy compared with conventional chemotherapy. As familiarity with these agents increases, it is becoming apparent that a significant number of patients treated with ICIs experience adverse...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7852999/ https://www.ncbi.nlm.nih.gov/pubmed/33526518 http://dx.doi.org/10.1136/bcr-2020-237217 |